USX:DCTH - Delcath Systems Inc Delcath Systems Inc
Sector: Health Care, Industry: Health Care Equipment
Next Earnings: 8 Aug 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 4.48    -0.02 (-0.44%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

24 May 2022


Loading...
Loading...
Loading...

General

CEO: Mr. Gerard J. Michel MBA, MS

IPO: 2018-05-29

Headquarters: US

Employees: 55

Homepage

Description

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Your Holdings
Dashboard
Portfolio
Options
Other Assets

Tools
Screener
Risk Manager
Other Assets
Watchlist
Alerts
Notes
Wall
Community
Forum
Blogs
Instagram
Facebook
Shared Portfolios
Shared Screeners

Collab
Tiger Brokers x StocksCafe
Saxo Trading x StocksCafe
Kenny REIT Screener

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
IG    FB    YouTube

About · FAQs · StocksCafe © 2022 · Privacy · Terms